Literature DB >> 18398093

Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer?

Francisco J Esteva, Gabriel N Hortobagyi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398093     DOI： 10.1093/jnci/djn098

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  To measure the unmeasurable.

Authors:  Michael Gnant
Journal:  World J Surg       Date:  2009-01       Impact factor: 3.352

Review 2.  Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: a systematic review.

Authors:  R Prevos; M L Smidt; V C G Tjan-Heijnen; M van Goethem; R G Beets-Tan; J E Wildberger; M B I Lobbes
Journal:  Eur Radiol       Date:  2012-09-16       Impact factor: 5.315

3.  Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography.

Authors:  Omar Falou; Ali Sadeghi-Naini; Sameera Prematilake; Ervis Sofroni; Naum Papanicolau; Sara Iradji; Zahra Jahedmotlagh; Sharon Lemon-Wong; Jean-Philippe Pignol; Eileen Rakovitch; Judit Zubovits; Jacqueline Spayne; Rebecca Dent; Maureen Trudeau; Jean Francois Boileau; Frances C Wright; Martin J Yaffe; Gregory J Czarnota
Journal:  Transl Oncol       Date:  2013-02-01       Impact factor: 4.243

4.  Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes.

Authors:  Shudong Jiang; Brian W Pogue; Colin M Carpenter; Steven P Poplack; Wendy A Wells; Christine A Kogel; Jorge A Forero; Lori S Muffly; Gary N Schwartz; Keith D Paulsen; Peter A Kaufman
Journal:  Radiology       Date:  2009-06-09       Impact factor: 11.105

5.  Preoperative systemic chemotherapy and pathologic assessment of response.

Authors:  Lajos Pusztai
Journal:  Pathol Oncol Res       Date:  2008-06-13       Impact factor: 3.201

6.  Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer.

Authors:  Hyeong-Gon Moon; Jae Kyo Yi; Hee Sung Kim; Hea Young Lee; Kyung-Min Lee; Minju Yi; Sookyung Ahn; Hee-Chul Shin; Ji-hyun Ju; Incheol Shin; Wonshik Han; Dong-Young Noh
Journal:  BMC Cancer       Date:  2012-12-10       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.